· GluCurve is the world’s first continuous glucose monitor (CGM) for diabetic dogs and cats
· GluCurve eliminates need for manual, costly and cumbersome “glucose curves” that are today’s standard of care
· 2017 AVMA Report shows between 28,000-32,000 veterinary practices in U.S.
· 97% of DVM survey respondents indicated they’d use a pet CGM system to diagnose and manage diabetic dogs and cats as soon as available
SINGAPORE, Oct 22 (Bernama-GLOBE NEWSWIRE) — ALR Technologies (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, is pleased to release select results from comprehensive market research conducted by the consulting firm SmartPharma, evaluating the current approach to diabetes diagnosis, glucose monitoring and insulin treatment in cats and dogs. The conclusions speak strongly about the market demand for innovation to modernize the arcane standard of care today, which ALRT interprets as highly favorable for introducing the GluCurve™ Pet CGM (continuous glucose monitoring) as a simple, accurate, reliable and pain-free system to treat the approximately 4.5 million diabetic dogs and cats worldwide.
- UN: 343 million people across 74 countries ‘acutely food insecure’
- COP29 braces for new deal after poorer nations reject climate offer
- Mpox still public health emergency: WHO
- Conflict In S. Lebanon: Zionists Killed Three Paramedics, Injured Four Peacekeepers
- Record 281 aid workers killed in 2024, says UN
- Authorities To Deploy Over 10,000 Additional Paramilitary Troopers In India’s Manipur
- Top DPRK Leader Calls For Upgrading Military Equipment
- 420,000 Syrian Refugees Return From Lebanon Due To Hezbollah-Israel Conflict
- Latest: 10 Naxals Killed In Gunfight In India’s Chhattisgarh
- 14th China-ASEAN Defence Ministers’ Informal Meeting Held In Laos